FI895555A0 - Menetelmä lääkkeenantojärjestelmän valmistamiseksi - Google Patents

Menetelmä lääkkeenantojärjestelmän valmistamiseksi

Info

Publication number
FI895555A0
FI895555A0 FI895555A FI895555A FI895555A0 FI 895555 A0 FI895555 A0 FI 895555A0 FI 895555 A FI895555 A FI 895555A FI 895555 A FI895555 A FI 895555A FI 895555 A0 FI895555 A0 FI 895555A0
Authority
FI
Finland
Prior art keywords
preparation
delivery system
drug delivery
drug
delivery
Prior art date
Application number
FI895555A
Other languages
English (en)
Swedish (sv)
Other versions
FI97444C (fi
FI97444B (fi
Inventor
Lisbeth Illum
Original Assignee
Danbiosyst Uk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Danbiosyst Uk filed Critical Danbiosyst Uk
Publication of FI895555A0 publication Critical patent/FI895555A0/fi
Application granted granted Critical
Publication of FI97444B publication Critical patent/FI97444B/fi
Publication of FI97444C publication Critical patent/FI97444C/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1658—Proteins, e.g. albumin, gelatin

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Otolaryngology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
FI895555A 1987-05-22 1989-11-21 Menetelmä lääkkeenantojärjestelmän valmistamiseksi FI97444C (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB878712176A GB8712176D0 (en) 1987-05-22 1987-05-22 Drug delivery system
GB8712176 1987-05-22
GB8800396 1988-05-20
PCT/GB1988/000396 WO1988009163A1 (en) 1987-05-22 1988-05-20 Enhanced uptake drug delivery system

Publications (3)

Publication Number Publication Date
FI895555A0 true FI895555A0 (fi) 1989-11-21
FI97444B FI97444B (fi) 1996-09-13
FI97444C FI97444C (fi) 1996-12-27

Family

ID=10617794

Family Applications (1)

Application Number Title Priority Date Filing Date
FI895555A FI97444C (fi) 1987-05-22 1989-11-21 Menetelmä lääkkeenantojärjestelmän valmistamiseksi

Country Status (10)

Country Link
EP (1) EP0391896B1 (fi)
JP (1) JP2914670B2 (fi)
AU (1) AU614290B2 (fi)
CA (1) CA1324079C (fi)
DE (1) DE3888201T2 (fi)
DK (1) DK175316B1 (fi)
FI (1) FI97444C (fi)
GB (2) GB8712176D0 (fi)
NO (1) NO178564C (fi)
WO (1) WO1988009163A1 (fi)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988001213A1 (en) * 1986-08-18 1988-02-25 Clinical Technologies Associates, Inc. Delivery systems for pharmacological agents
US4865850A (en) * 1986-09-08 1989-09-12 See/Shell Biotechnology, Inc. Dietary fat reduction
US5811128A (en) * 1986-10-24 1998-09-22 Southern Research Institute Method for oral or rectal delivery of microencapsulated vaccines and compositions therefor
US5075109A (en) * 1986-10-24 1991-12-24 Southern Research Institute Method of potentiating an immune response
US5298243A (en) * 1988-10-20 1994-03-29 Denki Kagaku Kogyo Kabushiki Kaisha Colony stimulating factor-gelatin conjugate
DE69027022T2 (de) * 1989-02-17 1996-11-28 Liposome Co Inc Lipidhilfstoffe für verabreichung durch die nase und örtliche anwendung
US5554388A (en) * 1989-02-25 1996-09-10 Danbiosyst Uk Limited Systemic drug delivery compositions comprising a polycationi substance
EP0465580A4 (en) * 1989-03-29 1992-03-18 Alcon Laboratories Inc Use of monoacyl phosphoglycerides to enhance the corneal penetration of ophthalmic drugs
US5725871A (en) * 1989-08-18 1998-03-10 Danbiosyst Uk Limited Drug delivery compositions comprising lysophosphoglycerolipid
GB8918879D0 (en) * 1989-08-18 1989-09-27 Danbiosyst Uk Pharmaceutical compositions
GB2237510B (en) * 1989-11-04 1993-09-15 Danbiosyst Uk Small particle drug compositions for nasal administration
US5707644A (en) * 1989-11-04 1998-01-13 Danbiosyst Uk Limited Small particle compositions for intranasal drug delivery
GB9001635D0 (en) * 1990-01-24 1990-03-21 Ganderton David Aerosol carriers
GB9012663D0 (en) * 1990-06-07 1990-08-01 Erba Carlo Spa Galenic formulations containing cyclodextrins
DK49791D0 (da) * 1991-03-20 1991-03-20 Novo Nordisk As Nasalt pulverpraeparat
IT1247472B (it) * 1991-05-31 1994-12-17 Fidia Spa Processo per la preparazione di microsfere contenenti componenti biologicamente attivi.
CA2094217A1 (en) * 1992-04-17 1993-10-18 Yasutaka Igari Transmucosal therapeutic composition
JPH08503950A (ja) * 1992-12-02 1996-04-30 アルカーメス・コントロールド・セラピユーテイクス・インコーポレーテツド 徐放性成長ホルモン含有マイクロスフェア
US5549908A (en) * 1993-05-20 1996-08-27 The University Of Akron Hydrolytically labile microspheres of polysaccharide crosslinked with cyanogen halide and their application in wound dressings
TW402506B (en) * 1993-06-24 2000-08-21 Astra Ab Therapeutic preparation for inhalation
US5506203C1 (en) * 1993-06-24 2001-02-06 Astra Ab Systemic administration of a therapeutic preparation
US5830853A (en) * 1994-06-23 1998-11-03 Astra Aktiebolag Systemic administration of a therapeutic preparation
IS1796B (is) * 1993-06-24 2001-12-31 Ab Astra Fjölpeptíð lyfjablanda til innöndunar sem einnig inniheldur eykjaefnasamband
US5747445A (en) * 1993-06-24 1998-05-05 Astra Aktiebolag Therapeutic preparation for inhalation
US6632456B1 (en) 1993-06-24 2003-10-14 Astrazeneca Ab Compositions for inhalation
SE9303574D0 (sv) * 1993-11-01 1993-11-01 Kabi Pharmacia Ab Composition for drug delivery and method the manufacturing thereof
US6165976A (en) 1994-06-23 2000-12-26 Astra Aktiebolag Therapeutic preparation for inhalation
BR9510516A (pt) 1994-12-22 1998-07-07 Astra Ab Preparação terapêutica uso da mesma dispositivo de inalação de pó seco processo de produção da preparação terapêutica e de tratamento de osteoporose
US6524557B1 (en) 1994-12-22 2003-02-25 Astrazeneca Ab Aerosol formulations of peptides and proteins
GB9522351D0 (en) * 1995-11-01 1996-01-03 Medeva Holdings Bv Vaccine compositions
US5985309A (en) * 1996-05-24 1999-11-16 Massachusetts Institute Of Technology Preparation of particles for inhalation
US5874064A (en) * 1996-05-24 1999-02-23 Massachusetts Institute Of Technology Aerodynamically light particles for pulmonary drug delivery
US6652837B1 (en) 1996-05-24 2003-11-25 Massachusetts Institute Of Technology Preparation of novel particles for inhalation
GB9700624D0 (en) 1997-01-14 1997-03-05 Danbiosyst Uk Drug delivery composition
US6391452B1 (en) 1997-07-18 2002-05-21 Bayer Corporation Compositions for nasal drug delivery, methods of making same, and methods of removing residual solvent from pharmaceutical preparations
US6565885B1 (en) 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
US6309623B1 (en) 1997-09-29 2001-10-30 Inhale Therapeutic Systems, Inc. Stabilized preparations for use in metered dose inhalers
US6433040B1 (en) 1997-09-29 2002-08-13 Inhale Therapeutic Systems, Inc. Stabilized bioactive preparations and methods of use
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
JP2000290184A (ja) * 1999-04-01 2000-10-17 Kyowa Hakko Kogyo Co Ltd 経鼻投与製剤
US7833549B2 (en) * 2000-01-19 2010-11-16 Mannkind Corporation Dry powder formulations of antihistamine for nasal administration
US8404217B2 (en) 2000-05-10 2013-03-26 Novartis Ag Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
PT1280520E (pt) 2000-05-10 2014-12-16 Novartis Ag Pós à base de fosfolípidos para administração de fármacos
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
GB0027357D0 (en) 2000-11-09 2000-12-27 Bradford Particle Design Plc Particle formation methods and their products
WO2003026699A1 (fr) * 2001-09-26 2003-04-03 Tanabe Seiyaku Co., Ltd. Compositions medicinales favorisant l'absorption de medicaments
DK1458360T3 (da) 2001-12-19 2011-08-29 Novartis Ag Pulmonær afgivelse af aminoglycosider
US9339459B2 (en) 2003-04-24 2016-05-17 Nektar Therapeutics Particulate materials
NL1022442C2 (nl) * 2003-01-20 2004-07-22 Tno Toepassing van lipide ter verbetring van de opname van nutrienten en (farmaceutisch) actieve stoffen.
JP4493594B2 (ja) * 2003-03-04 2010-06-30 田辺三菱製薬株式会社 粉末経鼻投与製剤
CA2528465A1 (en) * 2003-06-09 2005-01-20 Nastech Pharmaceutical Company Inc. Compositions and methods for enhanced mucosal delivery of growth hormone
MX350838B (es) 2011-02-11 2017-09-18 Grain Proc Corporation * Composicion de sal.
ES2848210T3 (es) 2014-01-27 2021-08-05 Yissum Res Dev Co Of Hebrew Univ Jerusalem Ltd Nanoencapsulación de compuestos activos hidrófilos

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3681500A (en) * 1969-12-12 1972-08-01 Boehringer Sohn Ingelheim Spray compositions for treatment of obstructive disorders of the respiratory tract and methods therefor
JPS59163313A (ja) 1983-03-09 1984-09-14 Teijin Ltd 経鼻投与用ペプチドホルモン類組成物
GB8514090D0 (en) * 1985-06-04 1985-07-10 Sandoz Ltd Organic compounds
WO1988001165A1 (en) * 1986-08-11 1988-02-25 Innovata Biomed Limited Pharmaceutical formulations comprising microcapsules

Also Published As

Publication number Publication date
DK583789A (da) 1990-01-18
NO178564B (no) 1996-01-15
DK175316B1 (da) 2004-08-16
NO890283D0 (no) 1989-01-23
DK583789D0 (da) 1989-11-21
CA1324079C (en) 1993-11-09
AU1793188A (en) 1988-12-21
NO890283L (no) 1989-01-23
NO178564C (no) 1996-04-24
JP2914670B2 (ja) 1999-07-05
EP0391896A1 (en) 1990-10-17
JPH02503915A (ja) 1990-11-15
DE3888201D1 (de) 1994-04-07
GB2231495A (en) 1990-11-21
DE3888201T2 (de) 1994-07-14
FI97444C (fi) 1996-12-27
FI97444B (fi) 1996-09-13
GB8924696D0 (en) 1990-09-05
EP0391896B1 (en) 1994-03-02
GB8712176D0 (en) 1987-06-24
GB2231495B (en) 1991-08-28
WO1988009163A1 (en) 1988-12-01
AU614290B2 (en) 1991-08-29

Similar Documents

Publication Publication Date Title
FI895555A0 (fi) Menetelmä lääkkeenantojärjestelmän valmistamiseksi
FI901787A0 (fi) Menetelmä lääkkeenvälityskoostumuksen valmistamiseksi
FI885884A (fi) Menetelmä hitaasti vapautuvan farmaseuttisen koostumuksen valmistamiseksi
FI98196B (fi) Menetelmä mikroemulsion käsittävän farmaseuttisen formulaation valmistamiseksi
FI884526A (fi) Menetelmä isradipiinia luovuttavan annosmuodon valmistamiseksi
FI880928A0 (fi) Menetelmä farmaseuttisen tabletin ja farmaseuttisen granulaatin valmistamiseksi
NO175515C (no) Fremgangsmåte for fremstilling av et farmasöytisk preparat for perkutan tilförsel
NO177038C (no) Fremgangsmåte for fremstilling av et farmasöytisk doseringssystem
FI892640A0 (fi) Menetelmä piperidinoalkanoli-ibuprofeeniyhdistelmää sisältävän farmaseuttisen koostumuksen valmistamiseksi
FI894342A (fi) Menetelmä syklosporiinia sisältävän farmaseuttisen koostumuksen valmistamiseksi
FI893520A0 (fi) Menetelmä intravenoosisen farmaseuttisen koostumuksen valmistamiseksi
FI900604A0 (fi) Menetelmä syklosporiinia sisältävän farmaseuttisen koostumuksen valmistamiseksi
FI880436A (fi) Menetelmä loisteaineen käsittelemiseksi
DK528988A (da) Laegemiddelafgivelsessystem
FI860101A (fi) Analogiamenetelmä uuden lääkkeen valmistamiseksi
FI883261A0 (fi) Menetelmä somatostatiinia sisältävän farmaseuttisen ainekoostumuksen valmistamiseksi
FI892058A0 (fi) Fenolin valmistusmenetelmä
FI880869A (fi) Menetelmä terapeuttisesti aktiivisten tetratsolijohdannaisten valmistamiseksi
FI881303A0 (fi) Menetelmä ibuprofeenin valmistamiseksi
FI875102A0 (fi) Analogiamenetelmä lääkeaineena käyttökelpoisen imidatsolijohdannaisen valmistamiseksi
FI104171B (fi) Menetelmä mono-N-alkyloitujen polyatsamakrosyklisten yhdisteiden valmistamiseksi
NO177485C (no) Fremgangsmåte for fremstilling av et farmasöytisk inhalasjonspreparat
FI92065C (fi) Menetelmä farmaseuttisten piperidiinijohdannaisten valmistamiseksi
NO179396C (no) Fremgangsmåte ved fremstilling av en medikamentell administreringsform for drövtyggere
FI913554A (fi) Menetelmä stabiloidun farmaseuttisen koostumuksen valmistamiseksi

Legal Events

Date Code Title Description
BB Publication of examined application
FG Patent granted

Owner name: WEST PHARMACEUTICAL SERVICES DRUG DELIVERY & CLINI

MA Patent expired